Center Laboratories, Inc. - Net Worth and Insider Trading

Center Laboratories, Inc. Net Worth

The estimated net worth of Center Laboratories, Inc. is at least $42 dollars as of 2025-05-31. Center Laboratories, Inc. is the 10% Owner of Windtree Therapeutics Inc and owns about 55 shares of Windtree Therapeutics Inc (WINT) stock worth over $42. Details can be seen in Center Laboratories, Inc.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Center Laboratories, Inc. has not made any transactions after 2021-12-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Center Laboratories, Inc.

To

Center Laboratories, Inc. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Center Laboratories, Inc. owns 1 companies in total, including Windtree Therapeutics Inc (WINT) .

Click here to see the complete history of Center Laboratories, Inc.’s form 4 insider trades.

Insider Ownership Summary of Center Laboratories, Inc.

Ticker Company Transaction Date Type of Owner
WINT Windtree Therapeutics Inc 2021-12-30 10 percent owner

Center Laboratories, Inc. Latest Holdings Summary

Center Laboratories, Inc. currently owns a total of 1 stock. Center Laboratories, Inc. owns 55 shares of Windtree Therapeutics Inc (WINT) as of December 30, 2021, with a value of $42.

Latest Holdings of Center Laboratories, Inc.

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
WINT Windtree Therapeutics Inc 2021-12-30 55 0.76 42

Holding Weightings of Center Laboratories, Inc.


Center Laboratories, Inc. Form 4 Trading Tracker

According to the SEC Form 4 filings, Center Laboratories, Inc. has made a total of 1 transactions in Windtree Therapeutics Inc (WINT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Windtree Therapeutics Inc is the acquisition of 29 shares on December 30, 2021, which cost Center Laboratories, Inc. around $2 Million.

Insider Trading History of Center Laboratories, Inc.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Center Laboratories, Inc. Trading Performance

GuruFocus tracks the stock performance after each of Center Laboratories, Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Center Laboratories, Inc. is -18.31%. GuruFocus also compares Center Laboratories, Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Center Laboratories, Inc. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Center Laboratories, Inc.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Center Laboratories, Inc.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -25.35 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -18.09 LIMIT LIMIT LIMIT LIMIT LIMIT

Center Laboratories, Inc. Ownership Network

Ownership Network List of Center Laboratories, Inc.

No Data

Ownership Network Relation of Center Laboratories, Inc.

Insider Network Chart


Center Laboratories, Inc. Owned Company Details

What does Windtree Therapeutics Inc do?

Who are the key executives at Windtree Therapeutics Inc?

Center Laboratories, Inc. is the 10 percent owner of Windtree Therapeutics Inc. Other key executives at Windtree Therapeutics Inc include director & Chief Executive Officer Craig Fraser , VP & Controller & & CAO Jamie Mcandrew , and SVP & CFO John P. Hamill .

Windtree Therapeutics Inc (WINT) Insider Trades Summary

Over the past 18 months, Center Laboratories, Inc. made no insider transaction in Windtree Therapeutics Inc (WINT). Other recent insider transactions involving Windtree Therapeutics Inc (WINT) include a net purchase of 5,431 shares made by Craig Fraser ,

In summary, during the past 3 months, insiders sold 0 shares of Windtree Therapeutics Inc (WINT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Windtree Therapeutics Inc (WINT) were sold and 109 shares were bought by its insiders, resulting in a net purchase of 109 shares.

Windtree Therapeutics Inc (WINT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Windtree Therapeutics Inc Insider Transactions

No Available Data

Center Laboratories, Inc. Mailing Address

Above is the net worth, insider trading, and ownership report for Center Laboratories, Inc.. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Center Laboratories, Inc.'s mailing address is: Taipei F5 11503.